eternalcreative/iStock via Getty Images Initial Takeaways From Q2 Report: GenesisX Submissions/Approval & MAGiC Making Progress Heading into the Q2 earnings report, I was most concerned about the GenesisX submission timeline. Stereotaxis (NYSE:STXS) management originally projected the robot would be submitted to regulators in late 2022. That guidance was way too aggressive. Then, in mid to late 2023, the firm suggested the robot was nearly ready for regulatory submission, but the company wanted to wait unti ...